Elite Pharmaceuticals Inc (ELTP)

[DR Ryan]

Revenue to market cap the stock is interesting in the .04's for long term value. $6-$7 million a Q currently with ANDA filings hopefully next year sets the stage for a great value, if you don't mind sitting on dead money for 12-24 months. (most investors wont, especially in OTC land hence the depressed PPS.)

Generics isn't a flashy business for sure. A big product or two approved would do wonders. Issue is an approval is ~18 months away. Can't see the share price going much lower unless revenues disintegrate. We'll see.